FP03.03 Clinical Activity of BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody, Plus Nivolumab in Small Cell Lung Cancer

Authors :: V. Surmont
C.M.L. van Herpen
Stephen Clarke
Natasha B. Leighl
K. Urbanska
G. Kollia
V. Andelkovic
S. Tannenbaum-Dvir
Neal Ready
Q. Chu
D. Lathers
Charles M. Rudin
Ben Markman
M. Acosta Rivera
Dong Wook Kim
C. He
M. Sanatani
S. Snow
P. Basciano
Rosalyn A. Juergens
A. Dipiero
A. Sibille
Source :: Journal of Thoracic Oncology. 16:S195
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
business.industry
medicine.drug_class
Cancer research
Medicine
Fucosyl GM1
Non small cell
Nivolumab
business
Monoclonal antibody

Tools